bibliographicCitation |
Andersson U, Smith D, Jeyakumar M, Butters TD, Borja MC, Dwek RA, Platt FM. Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. Neurobiol Dis. 2004 Aug;16(3):506–15. doi: 10.1016/j.nbd.2004.04.012. PMID: 15262262. |